Libby's H*O*P*E*
Harvard study finds that doxorubicin may actually drive the growth of ovarian cancer stem cells. Researchers also found that a protein called "Müllerian inhibiting substance" halts growth of cancer stem cells. Tumors - Science News - http://www.sciencenews.org/view...